DNAm landscape up to 4 months post SARS-CoV-2 infection: insights from four population-based cohorts.

Saved in:
Bibliographic Details
Title: DNAm landscape up to 4 months post SARS-CoV-2 infection: insights from four population-based cohorts.
Authors: Matías-García PR; Research Unit Molecular Epidemiology, Helmholtz Munich, Neuherberg, Germany. pamela.matiasgarcia@helmholtz-munich.de.; Institute of Epidemiology, Helmholtz Munich, Neuherberg, Germany. pamela.matiasgarcia@helmholtz-munich.de.; German Research Center for Cardiovascular Disease (DZHK), partner site Munich Heart Alliance, Munich, Germany. pamela.matiasgarcia@helmholtz-munich.de., Lai L; Research Unit Molecular Epidemiology, Helmholtz Munich, Neuherberg, Germany.; Institute of Epidemiology, Helmholtz Munich, Neuherberg, Germany.; Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany., Delerue T; Research Unit Molecular Epidemiology, Helmholtz Munich, Neuherberg, Germany.; Institute of Epidemiology, Helmholtz Munich, Neuherberg, Germany., Ohnmacht J; Luxembourg Institute of Health, Strassen, Luxembourg., Stark KJ; Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany., Warmerdam R; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Kolodkin A; Luxembourg Institute of Health, Strassen, Luxembourg., Six-Merker J; Institute of Epidemiology, Helmholtz Munich, Neuherberg, Germany., Mangold N; Institute of Epidemiology, Helmholtz Munich, Neuherberg, Germany.; Department for Diagnostic und Interventional Radiology, University Hospital Augsburg, Augsburg, Germany., Günther K; Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany., O'Sullivan MP; Luxembourg Institute of Health, Strassen, Luxembourg., Rauschenberger A; Luxembourg Institute of Health, Strassen, Luxembourg.; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg., Bohn B; NAKO e.V., Heidelberg, Germany., Berger K; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany., Fricke J; Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Unit for Municipal Health Strategies for the City of Freiburg and the District of Breisgau-Hochschwarzwald, Freiburg, Germany., Ahnert P; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Franke L; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Krüger R; Luxembourg Institute of Health, Strassen, Luxembourg.; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.; Centre Hospitalier du Luxembourg, Strassen, Luxembourg., Gefeller O; Department of Medical Informatics, Biometry and Epidemiology, Friedrich- Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Überla K; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Heid IM; Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany., Wagner R; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany.; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany., Waldenberger M; Research Unit Molecular Epidemiology, Helmholtz Munich, Neuherberg, Germany. melanie.waldenberger@helmholtz-munich.de.; Institute of Epidemiology, Helmholtz Munich, Neuherberg, Germany. melanie.waldenberger@helmholtz-munich.de.; German Research Center for Cardiovascular Disease (DZHK), partner site Munich Heart Alliance, Munich, Germany. melanie.waldenberger@helmholtz-munich.de., Peters A; Institute of Epidemiology, Helmholtz Munich, Neuherberg, Germany.; German Research Center for Cardiovascular Disease (DZHK), partner site Munich Heart Alliance, Munich, Germany.; Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Corporate Authors: Lifelines Corona Research Initiative, TiKoCo Working Group, CON-VINCE Consortium, NAKO Investigators, ORCHESTRA working group
Source: Clinical epigenetics [Clin Epigenetics] 2026 Jun 13; Vol. 18 (1). Date of Electronic Publication: 2026 Jun 13.
Publication Type: Journal Article
Journal Info: Publisher: Biomed Central Country of Publication: Germany NLM ID: 101516977 Publication Model: Electronic Cited Medium: Internet ISSN: 1868-7083 (Electronic) Linking ISSN: 18687075 NLM ISO Abbreviation: Clin Epigenetics Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1868-7083
DOI:10.1186/s13148-026-02166-1